跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TEVA-DILTIAZEM XC - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TEVA-DILTIAZEM XC
Authorized
STANDARD
TEVA-DILTIAZEM XC
teva canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
0f5029c2ff946ed5
Company
teva canada limited
Type
Standard
Approval Details
Approval Id
0f5029c2ff946ed5
Drug Approval Canada Name
TEVA-DILTIAZEM XC
Product Name
TEVA-DILTIAZEM XC
Status
Marketed
Status Date
2022-06-27
Original Market Date
2022-06-27
Din
02429349
Drug Class
Human
Dosage Form
Tablet (Extended-Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:28.92
Atc Original
C08DB01 DILTIAZEM
Atc Name
c 08 db 01
Aig Number
0115863008
Company Name
teva canada limited
Company Address
30 Novopharm Court, Toronto, Ontario, Canada, M1B 2K9
Active Ingredients
DILTIAZEM HYDROCHLORIDE
300 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
0f5029c2ff946ed5
Type
Standard
Back to Health Canada Approvals